These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20133415)

  • 21. Development and Validation of a PCR Assay To Detect the Prairie Epidemic Strain of Pseudomonas aeruginosa from Patients with Cystic Fibrosis.
    Workentine M; Poonja A; Waddell B; Duong J; Storey DG; Gregson D; Somayaji R; Rabin HR; Surette MG; Parkins MD
    J Clin Microbiol; 2016 Feb; 54(2):489-91. PubMed ID: 26659208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain.
    Lewis DA; Jones A; Parkhill J; Speert DP; Govan JR; Lipuma JJ; Lory S; Webb AK; Mahenthiralingam E
    Am J Respir Cell Mol Biol; 2005 Jul; 33(1):56-64. PubMed ID: 15834046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain.
    Williams D; Fothergill JL; Evans B; Caples J; Haldenby S; Walshaw MJ; Brockhurst MA; Winstanley C; Paterson S
    Microb Genom; 2018 Mar; 4(3):. PubMed ID: 29547097
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Keravec M; Mounier J; Guilloux CA; Fangous MS; Mondot S; Vallet S; Gouriou S; Le Berre R; Rault G; Férec C; Barbier G; Lepage P; Héry-Arnaud G
    BMJ Open Respir Res; 2019; 6(1):e000374. PubMed ID: 30956802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?
    Ashish A; Shaw M; Winstanley C; Ledson MJ; Walshaw MJ
    J Cyst Fibros; 2012 May; 11(3):173-9. PubMed ID: 22146482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
    Parsons YN; Panagea S; Smart CH; Walshaw MJ; Hart CA; Winstanley C
    J Clin Microbiol; 2002 Dec; 40(12):4607-11. PubMed ID: 12454160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
    Smart CHM; Walshaw MJ; Hart CA; Winstanley C
    J Med Microbiol; 2006 Jun; 55(Pt 6):677-688. PubMed ID: 16687584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients.
    Hall AJ; Fothergill JL; McNamara PS; Southern KW; Winstanley C
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):324-6. PubMed ID: 25284374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of susceptibility of cystic-fibrosis-related and non-cystic-fibrosis-related Pseudomonas aeruginosa to chlorine-based disinfecting solutions: implications for infection prevention and ward disinfection.
    Moore JE; Rendall JC
    J Med Microbiol; 2014 Sep; 63(Pt 9):1214-1219. PubMed ID: 24925907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.
    Srour N; Chaparro C; Vandemheen K; Singer LG; Keshavjee S; Aaron SD
    J Heart Lung Transplant; 2015 Apr; 34(4):588-93. PubMed ID: 25455752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.
    Cramer N; Wiehlmann L; Tümmler B
    Int J Med Microbiol; 2010 Dec; 300(8):526-33. PubMed ID: 20951087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
    Moore JE; Mastoridis P
    J Clin Pharm Ther; 2017 Jun; 42(3):259-267. PubMed ID: 28374433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Approach to Pseudomonas aeruginosa in Cystic Fibrosis.
    Talwalkar JS; Murray TS
    Clin Chest Med; 2016 Mar; 37(1):69-81. PubMed ID: 26857769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.
    Billard-Pomares T; Herwegh S; Wizla-Derambure N; Turck D; Courcol R; Husson MO
    J Med Microbiol; 2011 Feb; 60(Pt 2):157-161. PubMed ID: 20947668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
    Huus KE; Joseph J; Zhang L; Wong A; Aaron SD; Mah TF; Sad S
    J Immunol; 2016 Apr; 196(7):3097-108. PubMed ID: 26895832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation.
    Pritchard J; Thakrar MV; Somayaji R; Surette MG; Rabin HR; Helmersen D; Lien D; Purighalla S; Waddell B; Parkins MD
    J Cyst Fibros; 2016 May; 15(3):392-9. PubMed ID: 26657575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.
    Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA
    BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.